Apotex Corp.

HDA - Healthcare Distribution Alliance's Distribution Industry Award for Notable Achievements in Healthcare (DIANA) is one of the most distinguished awards in the pharmaceutical distribution industry, honoring pharmaceutical and consumer manufacturers for developing new and innovative products and promotions for the #healthcare distribution industry. Additionally, the awards recognize manufacturers' commitment to advancing #supplychain best practices through the organization's participation in HDA. We are pleased to share that Apotex Corp. received a DIANA award for being the First Merit Finalist in the Best Overall Generic Pharmaceutical Product Manufacturer category with over $100 million in sales to healthcare distributors. This award is a testament to our unwavering focus on innovation and ongoing commitment to improving patient access nationwide.

Fifty years ago today, on May 24, 1974, Apotex was officially incorporated by our founder, Dr. Barry Sherman, marking the start of a remarkable journey. From its humble beginnings with just two employees to the iconic organization it is today, Apotex's growth and achievements have been nothing short of extraordinary. Over the last five decades, Apotex has consistently advocated for improved access to affordable medicine, building a solid foundation rooted in positively impacting the patient's journey to health. The company's remarkable 50-year history exemplifies innovation, from leading the way with #biosimilars in Canada to launching complex products in the United States and other key international markets. Additionally, Apotex's global footprint is enhanced through robust commercial infrastructure and strategic expansions that underscore its commitment to patient access. Today, on our 50th anniversary, we are proud to be the largest Canadian-based #pharmaceutical company, represented by our top position in the number of prescriptions produced, diverse portfolio of products, and our significant and complex manufacturing capabilities. In looking to the future, we reaffirm our commitment of the last 50 years to increase access to #innovative medicines and health products through a renewed strategic focus to serve patients at every step along their journey to health. #Apotexat50

Now Available Cetrorelix Acetate for Injection 0.25mg. Learn more: https://lnkd.in/gbSuQmX3

May is Jewish American Heritage Month (JAHM), a time to recognize the contributions and experiences of Jewish Americans and highlight how America’s Jewish communities have shaped and been shaped by the cultural, social, and economic fabric of the United States. Learn more on how you can spread awareness here: https://lnkd.in/dRiRPYfz #JAHM

We are excited to attend the 20th Asembia Specialty Pharmacy Summit in Las Vegas this week among the nation's leading #pharmacy and pharmaceutical professionals. We look forward to meeting industry executives and strengthening relationships to enhance access to affordable medicine for millions of patients throughout the United States and beyond. #Asembia24

We are thrilled to participate again in this week's 2024 National Association of Chain Drug Stores (NACDS) Annual Meeting in Palm Beach, Florida. Visit us at booth #282 at #NACDSAnnual. We look forward to connecting with industry leaders to explore opportunities in today’s changing marketplace. #NACDS  

Apotex wishes you and your family a blessed Eid filled with happiness, prosperity, and good health.

We are pleased to receive the 2024 Distribution Management Award (DMA) at the 2024 Distribution Management Conference and Expo in Palm Desert, California. This award recognizes our efforts to provide an important chemotherapy drug amid a nationwide shortage. Congratulations to the team for their diligent work in ensuring patients receive their medication in a timely and efficient manner. Learn more: https://bit.ly/3TxEjID #DMC2024

Apotex Corp. is honored to receive the 2023 STAR Award for Operational Excellence at last week's Golden State Medical Supply, Inc. (GSMS) STAR Summit! This award signifies a partner who consistently delivers on time, engages effectively across project meetings, proactively brings forth any gaps in supply and collaborates on mitigation efforts. Congratulations to the team for this recognition! Pictured from left to right: David Arnold (GSMS), Sonia De La Rosa (GSMS), Michael Bohling (Apotex Corp.), Tina Kaus (Apotex Corp.), Shad Weaver (GSMS), Benjamin Hall (GSMS)

February 4 is #WorldCancerDay, dedicated to raising awareness and inspiring change for a cancer-free world. Apotex is proud to support the three-year campaign to #CloseTheCareGap – an initiative focused on reducing barriers in care. This year focuses on attaining a commitment from world leaders to prioritize cancer and design innovative strategies that confront inequality. Apotex remains committed to improving access to affordable medicines, and through our Apobiologix Partnership Program (APP), we look to optimize patient care and support in #oncology.